
<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>Tools for endoscopic management of benign luminal GI strictures</title>
<style>

<style>
body {
    font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
    background: linear-gradient(135deg, #f0f4ff, #fafafa);
    color: #2c2c2c;
    padding: 40px;
}

/* Mindmap container */
.mindmap {
    max-width: 900px;
    margin: auto;
    font-size: 16px;
    line-height: 1.7;
}

.mindmap ul {
    margin: 0.5em 0 1em 1em;
    padding-left: 1.5em;
    list-style: disc;
    color: #555;
    font-size: 0.95em;
    font-weight: 400;
    line-height: 1.6;
}

.mindmap li::marker {
    color: #a855f7; /* prettier bullets */
}

.mindmap li {
    margin-bottom: 6px;
    padding-left: 4px;
}


/* Collapsible sections */
.mindmap details {
    border-left: 4px solid #8b5cf6;
    background: #ffffff;
    margin: 15px 0;
    padding: 16px 20px;
    border-radius: 16px;
    box-shadow: 0 4px 12px rgba(139, 92, 246, 0.12);
    transition: all 0.3s ease;
    position: relative;
}

/* Hover glow */
.mindmap details:hover {
    box-shadow: 0 6px 18px rgba(139, 92, 246, 0.2);
    background: linear-gradient(135deg, #ffffff, #f3f0ff);
}

/* Summary styling */
.mindmap summary {
    cursor: pointer;
    font-size: 1.15em;
    font-weight: 600;
    list-style: none;
    position: relative;
    padding-left: 28px;
    color: #4c1d95;
}

/* Custom arrow */
.mindmap summary::before {
    content: "▶";
    position: absolute;
    left: 0;
    top: 2px;
    transition: transform 0.3s ease;
    font-size: 1em;
    color: #7c3aed;
}

.mindmap details[open] > summary::before {
    transform: rotate(90deg);
}

/* Titles */
.mindmap summary strong {
    display: block;
    font-size: 1.3em;
    color: #4c1d95;
}

.mindmap summary em {
    font-style: normal;
    color: #6b21a8;
    font-size: 0.95em;
}

/* Description bullets */
.mindmap ul {
    padding-left: 22px;
    margin-top: 10px;
    margin-bottom: 12px;
}

.mindmap li {
    margin-bottom: 6px;
    font-size: 0.97em;
    color: #444;
    list-style-type: disc;
    position: relative;
    padding-left: 4px;
}

/* Nesting indent style */
.mindmap details > div > details {
    margin-left: 20px;
    border-color: #a855f7;
    background: #f9f5ff;
}

/* Fade-in effect */
.mindmap details[open] > div {
    animation: fadeIn 0.3s ease-in;
}

/* Description box */
.mindmap .desc-box {
    background: #fdfcff;
    border: 1px solid #e5d9fb;
    border-left: 4px solid #c084fc;
    padding: 4px 6px;
    margin: 12px 0 18px 0;
    border-radius: 12px;
    box-shadow: 0 1px 3px rgba(160, 104, 255, 0.06);
    transition: background 0.3s ease;
}

.mindmap .desc-box:hover {
    background: #f9f4ff;
}


button {
    background-color: #7c3aed;
    color: white;
    border: none;
    padding: 10px 16px;
    margin: 0 6px;
    font-size: 1em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease;
}
button:hover {
    background-color: #6b21a8;
}


@keyframes fadeIn {
    from { opacity: 0; transform: translateY(-3px); }
    to { opacity: 1; transform: translateY(0); }
}


#level-controls button {
    background-color: rgba(124, 58, 237, 0.7); /* semi-transparent purple */
    color: white;
    border: none;
    padding: 8px 14px;
    margin: 0 6px;
    font-size: 1em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease, transform 0.2s;
}

#level-controls button:hover {
    background-color: rgba(107, 33, 168, 0.85); /* slightly darker on hover */
    transform: scale(1.05);
}

#level-controls {
    position: fixed;
    bottom: 20px;
    left: 50%;
    transform: translateX(-50%);
    background: rgba(124, 58, 237, 0.1);
    padding: 8px 14px;
    border-radius: 12px;
    box-shadow: 0 4px 10px rgba(0, 0, 0, 0.1);
    z-index: 9999;
    backdrop-filter: blur(6px);
    cursor: move; /* shows move cursor */
}

</style>




</style>
</head>
<body>
<div id="level-controls" onmousedown="dragElement(this)">
    <button onclick="setMindmapLevel(1)">Level 1</button>
    <button onclick="setMindmapLevel(2)">Level 2</button>
    <button onclick="setMindmapLevel(3)">Level 3</button>
</div>

<div class="mindmap">

    <div class="mindmap">
        
        <details>
            <summary><strong>Tools for endoscopic management of benign luminal GI strictures</strong></summary>
            <div>
                <ul><li>Source: ASGE TECHNOLOGY COMMITTEE</li><li>Journal: GASTROINTESTINAL ENDOSCOPY</li><li>Publication Year: 2025</li></ul>
                
        <details>
            <summary><strong>Knowledge Test</strong></summary>
            <div>
                <ul><li>1. What is the reported median perforation rate for pneumatic balloon dilation in achalasia when performed by an experienced endoscopist?</li><li>2. In refractory peptic esophageal strictures, what was the key finding of a randomized trial comparing intralesional steroid injection to sham injection?</li><li>3. What is the &quot;rule of 3&quot; in bougie dilation, and what have recent large studies shown about adherence to it?</li><li>4. For which type of benign esophageal stricture has electrosurgical incision therapy been shown to provide a longer remission of dysphagia compared to bougienage?</li><li>5. A meta-analysis comparing bougie and balloon dilators for benign esophageal strictures found no difference in major outcomes, but which method was associated with less post-procedure pain?</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Introduction to Benign Luminal GI Strictures</strong></summary>
            <div>
                <ul><li>Can occur in any part of the GI tract.</li><li>Arise from benign &amp; malignant causes.</li><li>Dilation is necessary when there is impaired passage of luminal contents, need for diagnosis, or therapy beyond the stricture.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Dilators for the GI Lumen</strong></summary>
            <div>
                <ul><li>Dilation is achieved by applying expansible forces against a stenosis.</li><li>Two main categories: fixed-diameter push-type dilators &amp; radial-expanding balloon dilators.</li></ul>
                
        <details>
            <summary><strong>Bougie Dilators</strong></summary>
            <div>
                <ul><li>Primarily used for esophageal strictures.</li><li>Exert both radial forces &amp; longitudinal shearing forces as they are advanced.</li></ul>
                
        <details>
            <summary><strong>Non–wire-guided</strong></summary>
            <div>
                <ul><li>Examples: Hurst (blunt tip) &amp; Maloney (tapered tip) dilators.</li><li>Characteristics: Flexible, radiopaque, tungsten-filled rubber bougies.</li><li>Use: Passed blindly w/ patient upright; rarely used for self-dilation now due to safety concerns.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Wire-guided</strong></summary>
            <div>
                <ul><li>Flexible, tapered, polyvinyl chloride tubes w/ a central channel for a guidewire.</li><li>Examples: Savary-Gilliard (most common), American Dilation System, SafeGuide.</li></ul>
                
        <details>
            <summary><strong>Features</strong></summary>
            <div>
                <ul><li>Savary-Gilliard: 20-cm long tapered tip, radiopaque band at maximal diameter.</li><li>American Dilation System/SafeGuide: Shorter tapered tip, radiopaque band throughout length.</li><li>CleanGuide: New disposable wire-guided bougie.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Reprocessing &amp; Durability</strong></summary>
            <div>
                <ul><li>Most bougies are reusable, but reprocessing is challenging.</li><li>Heightened cleaning/sterilization standards → ↓ durability &amp; cost-effectiveness of reusable devices.</li><li>Push for disposable dilators vs. &#x27;green endoscopy&#x27; focus on reducing waste.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Balloon Dilators</strong></summary>
            <div>
                <ul><li>Exert only radial forces when expanded within a stenosis.</li><li>Available in various designs, lengths, and calibers.</li></ul>
                
        <details>
            <summary><strong>Through-the-scope (TTS) Balloons</strong></summary>
            <div>
                <ul><li>Facilitate direct visual control during dilation.</li><li>Can be used w/ or w/o wire guidance.</li><li>Disposable, made of low-compliance thermoplastic polymers for uniform expansion.</li></ul>
                
        <details>
            <summary><strong>Technique</strong></summary>
            <div>
                <ul><li>Expanded by pressure injection of liquid (water or radiopaque contrast).</li><li>Pressure monitored manometrically.</li><li>Inflation w/ contrast enhances fluoroscopic assessment.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Achalasia Balloon Dilators</strong></summary>
            <div>
                <ul><li>Large-diameter (30, 35, 40 mm) polyethylene balloons.</li><li>Wire-guided, disposable, do not pass through the endoscope.</li><li>Positioned across the esophagogastric junction under fluoroscopy.</li></ul>
                
        <details>
            <summary><strong>Use</strong></summary>
            <div>
                <ul><li>Primary indication: Pneumatic dilation for achalasia.</li><li>Off-label use: Stenosis after gastric sleeve or fundoplication.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>BougieCap</strong></summary>
            <div>
                <ul><li>Single-use, transparent, conical hard plastic cap mounted on the endoscope tip.</li><li>The endoscope itself becomes the dilator, applying radial &amp; longitudinal shear forces.</li><li>Available in sizes 7-18 mm.</li></ul>
                
        <details>
            <summary><strong>Advantages</strong></summary>
            <div>
                <ul><li>Direct visual control &amp; tactile feedback → may prevent overdilation.</li><li>Real-time evaluation immediately after dilation.</li><li>Advantageous for high cervical esophageal strictures.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Evidence &amp; Safety</strong></summary>
            <div>
                <ul><li>Two prospective multicenter studies (50 patients each) showed technical feasibility, clinical efficacy, &amp; safety.</li><li>No significant adverse events reported.</li><li>Adverse Event: Slipping of the cap occurred in 3 cases.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>EsoFLIP</strong></summary>
            <div>
                <ul><li>Novel esophageal dilator incorporating high-resolution impedance planimetry.</li><li>Provides real-time graphic illustration of the esophageal lumen (diameter, cross-sectional area, etc.).</li><li>Enables therapeutic hydraulic dilation.</li></ul>
                
        <details>
            <summary><strong>Indications &amp; Sizes</strong></summary>
            <div>
                <ul><li>Use: Achalasia &amp; benign esophageal strictures (GERD, radiation, surgery).</li><li>Sizes: Up to 30-mm diameter for achalasia; up to 20-mm for benign strictures.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Potential Advantages</strong></summary>
            <div>
                <ul><li>Avoids fluoroscopy → ↓ radiation risk.</li><li>Controlled dilation over a wide range of diameters w/ a single balloon.</li><li>Objective measurement of stricture size &amp; immediate response to dilation.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Potential Disadvantages</strong></summary>
            <div>
                <ul><li>Not a TTS catheter.</li><li>Requires an external pressure monitor.</li><li>Guidewire must be removed before dilation.</li><li>Time required to fill &amp; empty the balloon.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Self-expandable Stents</strong></summary>
            <div>
                <ul><li>Used for refractory benign strictures, accomplishing dilation via their radial expansion forces.</li><li>Types: Covered self-expandable metal stents (SEMSs), self-expandable plastic stents, lumen-apposing metal stents (LAMSs).</li><li>Biodegradable stents are available but not in the United States.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Topical Use of Antifibrotic Drugs</strong></summary>
            <div>
                <ul><li>Used in refractory or recurrent benign esophageal strictures to reduce restenosis.</li></ul>
                
        <details>
            <summary><strong>Steroids (Intralesional/Oral)</strong></summary>
            <div>
                <ul><li>Use: Peptic, radiation-induced, caustic, &amp; anastomotic strictures.</li><li>Also used for prevention of stricture formation after EMR/ESD.</li></ul>
                
        <details>
            <summary><strong>Efficacy</strong></summary>
            <div>
                <ul><li>Randomized trial (peptic strictures): Intralesional steroid injection → fewer dilations over 1 year vs. sham.</li><li>Systematic review: Advantage for peptic, radiation-induced, &amp; caustic strictures; less clear for anastomotic.</li><li>Network meta-analysis (post-ESD): Oral or intralesional steroids → ↓ stenosis rate &amp; number of required dilations vs. placebo.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Mitomycin C (MMC)</strong></summary>
            <div>
                <ul><li>Chemotherapy agent w/ antifibrotic properties.</li><li>Common technique: 4-quadrant injections of 0.4 mg/mL MMC in 0.5 mL aliquots.</li></ul>
                
        <details>
            <summary><strong>Efficacy</strong></summary>
            <div>
                <ul><li>Systematic review (adults &amp; children): Complete response 73%, partial response 21%.</li><li>Study (anastomotic/post-ESD strictures): Dysphagia-free period was longer in MMC group (4.88 months) vs. dexamethasone (4.02 months) &amp; dilation alone (2.41 months).</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Paclitaxel</strong></summary>
            <div>
                <ul><li>Inhibits proliferation &amp; migration of fibroblasts.</li><li>Application: Paclitaxel-coated balloons.</li></ul>
                
        <details>
            <summary><strong>Evidence</strong></summary>
            <div>
                <ul><li>Pilot study: High technical success, no adverse events or stricture recurrence.</li><li>Further large-scale trials are needed.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>PuraStat</strong></summary>
            <div>
                <ul><li>Self-assembling peptide hypothesized to act as a biological wound dressing.</li><li>Protects wound from luminal stress, reducing inflammation &amp; fibrosis.</li><li>Studies show safety &amp; ease of application; long-term data needed.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Technique of Dilation</strong></summary>
            <div>
                <ul><li>Choice of dilator is determined by endoscopist preference &amp; clinical scenario.</li><li>Dilator diameter measured in mm or French (1 mm = 3F).</li></ul>
                
        <details>
            <summary><strong>General Principles</strong></summary>
            <div>
                <ul><li>Pre-procedure assessment: Location, length, diameter, etiology.</li><li>Biopsy to rule out malignancy.</li><li>Fluoroscopy guidance for complex strictures (angulated, long, very narrow).</li></ul>
                
        <details>
            <summary><strong>The &#x27;Rule of 3&#x27;</strong></summary>
            <div>
                <ul><li>Traditional rule for bougie dilation: After moderate resistance, pass no more than 3 dilators of progressively increasing diameter (≤3 mm per session).</li><li>Recent evidence: At least 2 large retrospective studies showed non-compliance did not ↑ risk of perforation or other adverse events.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Specific Scenarios &amp; Modifications</strong></summary>
            <div>
                <ul><li>Schatzki ring: A single large-diameter dilator (16-20 mm) is advocated to disrupt the ring.</li><li>Very narrow strictures: Initial dilation should be restricted to 10-12 mm.</li><li>Refractory strictures: May require steroid/antifibrotic injection, electrocautery incision, or stent placement.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Do&#x27;s and Don&#x27;ts</strong></summary>
            <div>
                <ul><li>DO: Perform comprehensive pre-procedure assessment &amp; obtain biopsies.</li><li>DO: Use wire-guidance &amp; fluoroscopy for complex cases to enhance safety.</li><li>DON&#x27;T: Overdilate; perform graded dilation.</li><li>DO: Consider alternative therapies (stents, surgery) for refractory strictures.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Outcomes &amp; Comparative Data</strong></summary>
            <div>
                <ul><li>Data varies based on stricture location and etiology.</li></ul>
                
        <details>
            <summary><strong>Esophagus</strong></summary>
            <div>
                <ul><li>Most common cause of benign strictures: GERD.</li><li>Simple strictures (&lt;2 cm, straight) vs. Complex (&gt;2 cm, tortuous, narrow).</li></ul>
                
        <details>
            <summary><strong>Bougie vs. Balloon Dilation</strong></summary>
            <div>
                <ul><li>Meta-analysis (5 trials, 461 patients): No significant difference in symptomatic relief, 1-year recurrence, bleeding, or perforation rates.</li><li>Finding: Balloon dilation associated w/ less severe post-procedure pain.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Schatzki Ring</strong></summary>
            <div>
                <ul><li>Treatment: Rupture of the ring.</li><li>Effective methods: Single large-caliber dilation (16-20 mm), biopsy disruption, electrosurgical incision.</li><li>Electrosurgical incision: May offer longer dysphagia remission vs. bougienage.</li><li>Medical therapy: Long-term PPI therapy significantly ↓ risk of relapse.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Anastomotic Strictures</strong></summary>
            <div>
                <ul><li>First-line therapy: Endoscopic interventions (balloon dilation, electrosurgical incision).</li><li>Radial incision &amp; cutting: May have higher 6-month &amp; 12-month patency rates vs. repeated balloon dilation for refractory cases.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Eosinophilic Esophagitis (EoE)</strong></summary>
            <div>
                <ul><li>Esophageal dilation is a safe &amp; effective treatment combined w/ medical/dietary therapy.</li><li>Bougie &amp; balloon dilators have similar safety &amp; efficacy profiles in EoE.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Refractory Strictures</strong></summary>
            <div>
                <ul><li>Rescue strategy: Temporary placement (6-12 weeks) of fully covered SEMS (FCSEMS).</li><li>Pooled clinical success rate for stents: 40.5%.</li><li>LAMS: Clinical success rate of 63%, but w/ an adverse event rate of 27.9%.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Achalasia</strong></summary>
            <div>
                <ul><li>Pneumatic balloon dilation (≥30 mm) is an accepted primary therapy.</li><li>Symptom relief: 74% (30 mm), 86% (35 mm), 90% (40 mm) of patients.</li><li>Long-term efficacy: Equivalent to laparoscopic Heller myotomy at 10-year follow-up.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Stomach &amp; Small Bowel</strong></summary>
            <div>
                <ul><li>Causes: PUD, NSAIDs, postsurgical changes, pancreaticobiliary disease.</li><li>Typically treated w/ TTS balloon dilators.</li></ul>
                
        <details>
            <summary><strong>Gastric Outlet Obstruction (GOO)</strong></summary>
            <div>
                <ul><li>First-line treatment: Endoscopic balloon dilation.</li><li>Failure more likely in: Long strictures (&gt;3 cm), caustic ingestion, chronic pancreatitis.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Crohn&#x27;s Disease</strong></summary>
            <div>
                <ul><li>Endoscopic balloon dilation is efficacious, especially for strictures &lt;4 cm.</li><li>Success rates: Technical 92.6%, Clinical 70.2%.</li><li>Adverse events: Overall 6.4%, Perforation 3%.</li><li>Long-term outcome: Cumulative surgery rate at 5 years is 75%.</li></ul>
                
        <details>
            <summary><strong>Stents in Crohn&#x27;s Disease</strong></summary>
            <div>
                <ul><li>FCSEMS are not first-line therapy.</li><li>ProtDilat trial: Endoscopic balloon dilation was superior to FCSEMS; 80% of balloon group vs. 51% of stent group were free of re-intervention at 1 year.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Colon</strong></summary>
            <div>
                <ul><li>Etiologies: Anastomotic, NSAIDs, diverticulitis, radiation, IBD.</li><li>Balloon or bougie-type dilators are effective.</li></ul>
                
        <details>
            <summary><strong>Comparative Data</strong></summary>
            <div>
                <ul><li>Prospective trial (anastomotic strictures): Large pneumatic balloon (35 mm) required fewer sessions (1.6 vs 2.6) &amp; had longer response (560 vs 245 days) compared to smaller TTS balloon (18 mm).</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Safety &amp; Adverse Events</strong></summary>
            <div>
                <ul><li>Endoscopic dilation is generally safe when performed by experienced endoscopists.</li><li>Minor mucosal tears &amp; bleeding are expected.</li></ul>
                
        <details>
            <summary><strong>Perforation</strong></summary>
            <div>
                <ul><li>Most clinically significant adverse event.</li><li>Overall rate for esophageal strictures: 0.1% to 0.6%.</li></ul>
                
        <details>
            <summary><strong>Risk Factors</strong></summary>
            <div>
                <ul><li>Stricture-related: Narrow, angulated, caustic, or radiation-induced.</li><li>Patient-related: Large hiatal hernia, esophageal diverticula.</li><li>Operator-related: Inexperience.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Specific Scenarios</strong></summary>
            <div>
                <ul><li>EoE: Dilation is NOT associated w/ a higher perforation risk.</li><li>Achalasia: Median perforation rate w/ pneumatic dilation is 1.9% (range 0-16%).</li><li>GOO: Perforation occurred in 3.4% of cases in a large series.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Other Adverse Events</strong></summary>
            <div>
                <ul><li>Bacteremia: Transient bacteremia reported in up to 23% of cases; prophylactic antibiotics not routinely recommended.</li><li>Bleeding: Clinically significant bleeding occurs in &lt;0.5% of cases.</li><li>Electrosurgical Incision: Associated w/ a perforation risk of up to 3.5%.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Financial Considerations</strong></summary>
            <div>
                <ul><li>Reusable dilators offer cost benefits over disposable devices, even with reprocessing expenses.</li><li>Stents are significantly more expensive than dilation catheters &amp; balloons.</li></ul>
                
        <details>
            <summary><strong>CPT Codes &amp; Reimbursement (2023 Medicare National Average)</strong></summary>
            <div>
                <ul><li>Esophageal Dilation (Balloon &lt;30mm): CPT 43220/43249</li><li>Esophageal Dilation (over guidewire): CPT 43226</li><li>Achalasia Dilation (Balloon &gt;30mm): CPT 43233</li><li>Gastric Outlet Dilation: CPT 43245</li><li>Colonoscopy w/ Balloon Dilation: CPT 45386</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Areas for Future Research</strong></summary>
            <div>
                <ul><li>Optimal technique for refractory strictures needs clarification.</li><li>Prospective studies needed on antifibrotic drugs to reduce recurrence.</li><li>Head-to-head comparisons between newer stents (e.g., LAMSs) and traditional dilation techniques are needed.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Conclusions</strong></summary>
            <div>
                <ul><li>Fixed-diameter push-type dilators &amp; radial expansion balloon dilators are safe &amp; effective for benign GI strictures.</li><li>Both approaches have similar efficacy &amp; safety profiles.</li><li>Newer technologies (EsoFLIP, BougieCap, stents, electroincision) address limitations of older tools.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
    </div>
    
</div>


<script>
function setMindmapLevel(level) {
    const allDetails = document.querySelectorAll('.mindmap details');

    // Close all
    allDetails.forEach(detail => detail.removeAttribute('open'));

    // Open based on depth
    allDetails.forEach(detail => {
        let depth = 0;
        let parent = detail.parentElement;
        while (parent && parent.tagName !== 'BODY') {
            if (parent.tagName === 'DETAILS') depth++;
            parent = parent.parentElement;
        }
        if (depth < level) detail.setAttribute('open', '');
    });
}

// Automatically open to level 1 on page load
window.addEventListener('DOMContentLoaded', () => {
    setMindmapLevel(1);
});

function dragElement(elmnt) {
    let pos1 = 0, pos2 = 0, pos3 = 0, pos4 = 0;

    const onMouseDown = (e) => {
        e.preventDefault();
        pos3 = e.clientX;
        pos4 = e.clientY;
        document.onmouseup = closeDragElement;
        document.onmousemove = elementDrag;
    };

    const elementDrag = (e) => {
        e.preventDefault();
        pos1 = pos3 - e.clientX;
        pos2 = pos4 - e.clientY;
        pos3 = e.clientX;
        pos4 = e.clientY;
        elmnt.style.top = (elmnt.offsetTop - pos2) + "px";
        elmnt.style.left = (elmnt.offsetLeft - pos1) + "px";
        elmnt.style.transform = "none"; // cancel centering transform
        elmnt.style.bottom = "auto"; // cancel fixed bottom
    };

    const closeDragElement = () => {
        document.onmouseup = null;
        document.onmousemove = null;
    };

    onMouseDown(event);
}
</script>


</body>
</html>
